CLINICAL_TRIALS
withdrawal
· 2015-05-06
Clinical Trial Update: TSO for Plaque Psoriasis [Phase 2]
Summary
A Phase 2 trial evaluating TSO for plaque psoriasis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Coronado Biosciences, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: WITHDRAWN